When the PD-1 receptor and the PD-L1 ligand interact, a signal-inhibiting T cell receptor (TCR)-mediated activation occurs, which results in a lack of T-cell activity and continued tumor progression [47]. The gene discussed is CD274; the disease is neoplasm.